Immunolines

Collaborating cohorts working on Immune Mediated Inflammatory Diseases (IMID) Cohort

Collaborating cohorts working on Immune Mediated Inflammatory Diseases (IMID)

Immunolines is a collaborative effort of clinical and research departments. We provide an overview of the available data‑biobanks in the UMCG from auto-immune and auto-inflammatory diseases together called IMID (Immune Mediated Inflammatory Diseases).

Immunolines facilitates translational research in and across IMID’s within and outside the UMCG. Our cohorts have as a central goal to increase the understanding of disease mechanisms underlying the immune-mediated diseases including their variety in severity, involved organs and pathways underlying active disease in order to improve early recognition and outcome with targetedtreatment.

Immunolines aims to:

facilitates early recognition;
facilitates translation between the IMIDs;
facilitates personalized care and treatment;
increases awareness and collaboration on laboratory facilities for sampling and analysis of biological material.

-   Systemic Lupus Erythematosus and Systemic sclerosis
-   Sjögren Expertise Centre
-   Vasculitis Expertise Center
-   The Groningen Leeuwarden Axiale Spondylartritis (GLAS)

See also: research groups of the UMCG research department Rheumatology and Clinical Immunology
Immunolines will provide an overview of:
- clinical data
- questionnaire and patient reported outcome data
- biological samples
- immunological techniques
UMCG Allergology
- Insects Allergy database - Hanneke Oude Elberink
UMCG Dermatology
- HiCARE Hidradenitis Suppurativa Zorgpad Noord-Oost Nederland
- UMCG Center for Blister Diseases (in Dutch)
UMCG Gastrointestinal and liver diseases
- parelsnoer cohort
- 1000 IBD: UMCG Inflammatory Bowel Disease Center (in Dutch)
- Celiac Disease North Netherlands
UMCG Pediatric Rheumatology
- REPSULT
- Vasculitis: UMCG Expertisecentrum Vasculitis (in Dutch)
- Juveniele Idiopathische Artritis (JIA): UMCG Expertisecentrum voor Systeemziekten en Reumatologische Aandoeningen op de Kinderleeftijd (in Dutch)
UMCG Rheumatology and Clinical Immunology
- GPS cohort (GCA/PMR/SENEX)
- B-reg cohort (ANCA geassocieerde vasculitis)
- RESULT cohort (Sjögren)
- GLAS cohort (axiale SpA)
- iSLE cohort (SLE)
UMCG Internal medicine
- Raynaud lines
UMCG Research Departments for immunological techniques
- Medical Immunology
- Medical genetics
- Medical microbiology
- Pathology and medical biology
Collaborations & Partnerships
- UMCG Research Institutes GUIDE
- Target to Be
- Immune Health XL
UMCG Reumatologie en Klinische Immunologie (in Dutch)

Discover our research

News

Successful First Symposium for Transplantlines Patients

News

Large grant awarded for future-proof Primary Care

News

University of Groningen invests 30 million euros in research thanks to donation

Relevance

How Immunolines benefits to society

UMCG promotes healthy ageing. To this end the UMCG founded European research institute for the biology of ageing (ERIBA) and supports Lifelines a population based cohort and cohort initiatives. For healthy ageing in IMID’s it is necessary that the patient is recognized in an early stage of the disease before damage occurs. The Immunolines cohort studies and biobanking are in line with the FAIR (findable accessible interoperable reusable) principles, are unique in the world and are perfect for international collaboration and funding. Together with Translational Immunology Groningen (TRIGR) one of the research programs within the Groningen University Institute for Drug Exploration (GUIDE) which aims to unravel the pathophysiological mechanisms underlying immune-mediated chronic diseases and to be a platform for translational immunological research.